Tom Yang

Tom is a principal in Monitor Deloitte’s San Francisco office and a member of the life sciences strategy practice. He brings over 15 years of experience assisting biopharma and medtech executives navigate uncertainty in the healthcare ecosystem and deliver growth strategies. Tom leads Deloitte’s perspective on the implications of the Future of Health for the Biopharma sector and the forces, from within and without, that will redefine the shape of the industry. He helps his clients adapt and thrive by addressing a wide range of topics such as: corporate strategy, digital transformation, business development, product development and commercialization strategy, market access, and building organizational capabilities.

Tom received his Ph.D. in Cell and Molecular Biology from the University of Pennsylvania School of Medicine, where he characterized the role of a novel AMPK-family kinase in mammary tumorigenesis and metastasis. Tom graduated from Cornell University with a bachelors in Microbiology and Economics.